Stocks · Healthcare · Medical - Diagnostics & Research
Agilent Technologies, Inc. A
$167.78 +0.66% Close, Oct 2, 2026 · NYSE · Market cap $47.38B
Low risk
Next earnings report: Nov 23, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in an uptrend: above its 200-day average for 53 trading days, with the 50-day average above the 200-day.
- Diluted EPS over the last four quarters was $5.08, up 19.2% year over year.
- Revenue over the last four quarters was $7.37B, up 8.6% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 49%
- EPS growth (TTM, YoY)Top 42%
- FCF growth (TTM, YoY)Top 38%
- Revenue growth, 3-year CAGRBottom 25%
- Revenue growth accelerationBottom 47%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 12%
- Gross marginBottom 37%
- Operating marginTop 11%
- Cash conversion (OCF / net income)Bottom 25%
- Accruals (lower is better)Bottom 20%
- Net debt / EBITDA (lower is better)Top 49%
- Interest coverTop 11%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 19%
- Free-cash-flow yieldTop 26%
- EBITDA / enterprise valueTop 27%
- Sales / enterprise valueBottom 39%
- P/E vs own 5-year history (lower is better)Bottom 22%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 41%
- 6-month returnTop 21%
- 1-year return vs S&P 500Top 43%
- Distance from 52-week highTop 6%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 50%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyTop 44%
- Upside to consensus price targetBottom 11%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 8%
- Maximum drawdown, 3 yearsTop 9%
- Beta vs S&P 500 (lower is better)Top 40%
- Net debt / EBITDA (lower is better)Top 49%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 9.1% | 8.6% | ↓ |
| EPS growth (YoY) | 23.0% | 19.2% | ↓ |
| Gross margin | 53.0% | 53.7% | ↑ |
| Operating margin | 21.3% | 22.2% | ↑ |
| FCF margin | 16.0% | 19.5% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 8.6% | 9.1% | ↓ | Bottom 49% |
| EPS growth (TTM, YoY) | 19.2% | 23.0% | ↓ | Top 42% |
| Gross margin | 53.7% | 53.0% | ↑ | Bottom 37% |
| Operating margin | 22.2% | 21.3% | ↑ | Top 11% |
| Net margin | 19.5% | 18.0% | ↑ | — |
| Free-cash-flow margin | 19.5% | 16.0% | ↑ | — |
| Return on invested capital | 11.9% | — | Top 12% | |
| Revenue growth, 3-year CAGR | 0.5% | — | Bottom 25% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.12×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.11×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 15.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.60%
- Net buyback yield (TTM)
- 0.64%
- Shareholder yield
- 1.25%
- Share count change, 1 year
- -0.7%
- Share count change, 3-year CAGR
- -1.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jul 31, 2026 (filed Sep 1, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +3.5%
- Average 2-day reaction, last 8
- +0.4%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $170.00
- Target vs current price
- +1.3%
- Analysts with a rating
- 41
- Share rating Buy or Strong Buy
- 80%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 26, 2026 | +8.7% | +0.2% | -3.1% | +6.8% | — |
| May 27, 2026 | +5.7% | +0.7% | +17.4% | +14.4% | +35.8% |
| Feb 25, 2026 | -0.7% | +0.3% | -4.3% | -8.2% | -8.5% |
| Nov 24, 2025 | +0.4% | +1.6% | -0.8% | -8.4% | -18.7% |
| Aug 27, 2025 | +0.0% | +0.3% | +5.8% | +5.1% | +22.1% |
| May 28, 2025 | +4.0% | -0.3% | +1.3% | +6.6% | +5.3% |
| Feb 26, 2025 | +2.3% | +0.2% | -8.3% | -10.2% | -18.8% |
| Nov 25, 2024 | +3.5% | +0.5% | +4.3% | +0.6% | +1.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 26, 2026 | $1.62 | $1.49 | +8.7% | $1.88B |
| May 27, 2026 | $1.49 | $1.41 | +5.7% | $1.83B |
| Feb 25, 2026 | $1.36 | $1.37 | -0.7% | $1.80B |
| Nov 24, 2025 | $1.59 | $1.58 | +0.4% | $1.84B |
| Aug 27, 2025 | $1.37 | $1.37 | +0.0% | $1.74B |
| May 28, 2025 | $1.31 | $1.26 | +4.0% | $1.67B |
| Feb 26, 2025 | $1.31 | $1.28 | +2.3% | $1.68B |
| Nov 25, 2024 | $1.46 | $1.41 | +3.5% | $1.70B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 33.0× | 30.4× | 76th | Top 19% |
| P/E (forward) | 27.1× | — | — | — |
| EV / EBITDA | 25.2× | — | — | Top 27% |
| EV / Sales | 6.72× | — | — | Bottom 39% |
| Free-cash-flow yield | 3.03% | — | — | Top 26% |
| Earnings yield | 3.03% | — | — | Top 19% |
P/E over the past five years
Range 26.3× – 54.8× since Jul 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +21.1%
- Earnings per share growth (TTM)
- +19.2%
- Change in P/E multiple
- +0.0%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 93
- Days above the 200-day average
- 53
- 50-day average slope (20 days)
- +7.4%
- 200-day average slope (20 days)
- +1.0%
- Distance from 50-day average
- +10.0%
- Distance from 200-day average
- +26.3%
- RSI (14)
- 61.2
- Relative volume
- 0.93×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 29.3%
- Volatility vs own 5-year history
- 54th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.96
- Correlation with S&P 500
- 0.44
- Current drawdown from 1-year high
- -4.2%
- Maximum drawdown, 3 years
- -35.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 3, 2021 | Apr 8, 2025 | -44.6% | 901 days | Not yet recovered |
| Feb 17, 2021 | Mar 4, 2021 | -11.6% | 11 days | 22 days (Apr 6, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $47.38B
- P/E (TTM)
- 33.0
- EPS, diluted (TTM)
- $5.08
- Revenue (TTM)
- $7.37B
- Dividend yield
- 0.61%
- 52-week range
- $108.35 – $177.05
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $6.32B | $6.85B | $6.83B | $6.51B | $6.95B |
| Gross profit | $3.41B | $3.72B | $3.46B | $3.54B | $3.64B |
| Operating income | $1.35B | $1.62B | $1.35B | $1.49B | $1.48B |
| Net income | $1.21B | $1.25B | $1.24B | $1.29B | $1.30B |
| EPS (diluted) | $3.94 | $4.18 | $4.19 | $4.43 | $4.57 |
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.70B | $1.68B | $1.67B | $1.74B | $1.86B | $1.80B | $1.83B | $1.88B |
| Net income | $351.0M | $318.0M | $215.0M | $336.0M | $434.0M | $305.0M | $339.0M | $362.0M |
| EPS (diluted) | $1.22 | $1.11 | $0.75 | $1.18 | $1.53 | $1.07 | $1.20 | $1.28 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $1.49B | $1.31B | $1.77B | $1.75B | $1.56B |
| Capital expenditure | -$189.0M | -$291.0M | -$298.0M | -$378.0M | -$407.0M |
| Free cash flow | $1.30B | $1.02B | $1.47B | $1.37B | $1.15B |
| Dividends paid | -$236.0M | -$250.0M | -$265.0M | -$274.0M | -$282.0M |
| Net share buybacks | -$788.0M | -$1.14B | -$575.0M | -$1.15B | -$353.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.76B
- Total assets
- $13.97B
- Total liabilities
- $6.60B
- Total debt
- $3.95B
- Net debt
- $2.19B
- Shareholders’ equity
- $7.36B
As of Jul 31, 2026 (filed Sep 1, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Oct 6, 2026 | $0.26 | Oct 28, 2026 |
| Jun 30, 2026 | $0.26 | Jul 22, 2026 |
| Mar 31, 2026 | $0.26 | Apr 22, 2026 |
| Jan 6, 2026 | $0.26 | Jan 28, 2026 |
| Sep 30, 2025 | $0.25 | Oct 22, 2025 |
| Jul 1, 2025 | $0.25 | Jul 23, 2025 |
| Apr 1, 2025 | $0.25 | Apr 23, 2025 |
| Dec 31, 2024 | $0.25 | Jan 22, 2025 |
Short interest
- Shares sold short
- 5,078,629
- Days to cover
- 2.54
- Change vs previous report
- -10.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 3, 2014
- 699-for-500